Morphic Therapeutic Announces Participation in September Investor Conferences

Rhea-AI Summary

Morphic Therapeutic (Nasdaq: MORF) will participate in two major investor conferences. CEO Dr. Praveen Tipirneni and COO Marc Schegerin will hold a fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on September 10 at 12:30 p.m. ET. They will also host virtual meetings during the Citi 16th Annual BioPharma Virtual Conference from September 8 to 10. A live webcast of the fireside chat will be available on Morphic’s website, with an archived replay to follow.

Positive

• Participation in significant investor conferences could enhance visibility and investor interest.
• Live webcast and archived replay of the fireside chat improve investor accessibility.

Negative

• None.

WALTHAM, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced participation in the following investor conferences:

• Dr. Praveen Tipirneni, M.D., President and CEO, and Marc Schegerin, M.D., COO and CFO, are scheduled to take part in a fireside chat at the Morgan Stanley 19^th Annual Global Healthcare Conference at 12:30 p.m. ET on Friday, September 10
• Members of the Morphic management team will host virtual meetings during the Citi 16^th Annual BioPharma Virtual Conference taking place from September 8 to 10

A live webcast of the Morgan Stanley fireside chat will be available on the Investor section of Morphic’s website at www.morphictx.com. An archived replay will be available on the company’s website following the conference.

About Morphic Therapeutic
Morphic Therapeutic is a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis and cancer. In collaboration with AbbVie, Janssen, and Schrödinger, Morphic is advancing its pipeline and discovery activities using its proprietary MInT technology platform which leverages the Company’s unique understanding of integrin structure and biology. For more information, visit www.morphictx.com.

Contacts
Morphic Therapeutic
Chris Erdman
chris.erdman@morphictx.com
617.686.1718

Media Contact
Tom Donovan, Ten Bridge Communications
tom@tenbridgecommunications.com
857.559.3397

FAQ

What investor conferences is Morphic Therapeutic attending in September 2021?

Morphic Therapeutic is participating in the Morgan Stanley 19th Annual Global Healthcare Conference and the Citi 16th Annual BioPharma Virtual Conference.

When will Morphic Therapeutic's fireside chat take place?

The fireside chat is scheduled for September 10, 2021, at 12:30 p.m. ET.

Where can I watch the live webcast of Morphic Therapeutic's fireside chat?

The live webcast will be available on Morphic Therapeutic's investor section of their website.

What are the dates of the Citi 16th Annual BioPharma Virtual Conference?

The Citi conference will take place from September 8 to 10, 2021.